个性化文献订阅>期刊> Cell
 

Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model

  作者 Zhang, BC; Kracker, S; Yasuda, T; Casola, S; Vanneman, M; Homig-Holzel, C; Wang, Z; Derudder, E; Li, S; Chakraborty, T; Cotter, SE; Koyama, S; Currie, T; Freeman, GJ; Kutok, JL; Rodig, SJ; Dranoff, G; Rajewsky, K  
  选自 期刊  Cell;  卷期  2012年148-4;  页码  739-751  
  关联知识点  
 

[摘要]B cells infected by Epstein-Barr virus (EBV), a transforming virus endemic in humans, are rapidly cleared by the immune system, but some cells harboring the virus persist for life. Under conditions of immunosuppression, EBV can spread from these cells and cause life-threatening pathologies. We have generated mice expressing the transforming EBV latent membrane protein 1 (LMP1), mimicking a constitutively active CD40 coreceptor, specifically in B cells. Like human EBV-infected cells, LMP1(+) B cells were efficiently eliminated by T cells, and breaking immune surveillance resulted in rapid, fatal lymphoproliferation and lymphomagenesis. The lymphoma cells expressed ligands for a natural killer (NK) cell receptor, NKG2D, andcould betargetedby anNKG2D-Fc fusion protein. These experiments indicate a central role for LMP1 in the surveillance and transformation of EBV-infected B cells in vivo, establish a preclinical model for B cell lymphomagenesis in immunosuppressed patients, and validate a new therapeutic approach.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内